Advanced Medical Solutions Group Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Advanced Medical Solutions Group wird ein jährliches Gewinn- und Umsatzwachstum von 14.8% bzw. 18.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.4% betragen.
Wichtige Informationen
23.6%
Wachstumsrate der Gewinne
21.5%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 22.9% |
| Wachstumsrate der Einnahmen | 16.3% |
| Zukünftige Eigenkapitalrendite | 5.4% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07
Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07
Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18How Much Is Advanced Medical Solutions Group plc (LON:AMS) Paying Its CEO?
Dec 28Calculating The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Dec 10The Advanced Medical Solutions Group (LON:AMS) Share Price Is Up 38% And Shareholders Are Holding On
Nov 20Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 245 | 18 | 21 | 38 | 8 |
| 12/31/2025 | 230 | 17 | 25 | 36 | 8 |
| 12/31/2024 | 178 | 10 | 15 | 21 | 8 |
| 6/30/2024 | 131 | 11 | 6 | 15 | N/A |
| 3/31/2024 | 129 | 14 | 4 | 14 | N/A |
| 12/31/2023 | 126 | 16 | 2 | 12 | N/A |
| 9/30/2023 | 128 | 18 | 5 | 15 | N/A |
| 6/30/2023 | 129 | 20 | 8 | 18 | N/A |
| 3/31/2023 | 127 | 20 | 12 | 23 | N/A |
| 12/31/2022 | 124 | 20 | 17 | 27 | N/A |
| 9/30/2022 | 121 | 19 | 19 | 28 | N/A |
| 6/30/2022 | 117 | 18 | 22 | 30 | N/A |
| 3/31/2022 | 113 | 18 | 23 | 30 | N/A |
| 12/31/2021 | 109 | 17 | 25 | 31 | N/A |
| 9/30/2021 | 103 | 16 | 23 | 29 | N/A |
| 6/30/2021 | 98 | 14 | 21 | 26 | N/A |
| 3/31/2021 | 92 | 11 | 18 | 24 | N/A |
| 12/31/2020 | 87 | 9 | 16 | 22 | N/A |
| 9/30/2020 | 90 | 11 | 15 | 21 | N/A |
| 6/30/2020 | 93 | 14 | 15 | 20 | N/A |
| 3/31/2020 | 98 | 16 | 15 | 21 | N/A |
| 12/31/2019 | 102 | 19 | 16 | 22 | N/A |
| 9/30/2019 | 103 | 20 | 15 | 20 | N/A |
| 6/30/2019 | 104 | 21 | 14 | 19 | N/A |
| 3/31/2019 | 103 | 22 | 16 | 20 | N/A |
| 1/1/2019 | 103 | 22 | 17 | 22 | N/A |
| 9/30/2018 | 101 | 22 | N/A | N/A | N/A |
| 6/30/2018 | 98 | 22 | 18 | 23 | N/A |
| 3/31/2018 | 98 | 21 | N/A | 20 | N/A |
| 12/31/2017 | 97 | 20 | N/A | 17 | N/A |
| 9/30/2017 | 94 | 19 | N/A | N/A | N/A |
| 6/30/2017 | 90 | 17 | N/A | 18 | N/A |
| 3/31/2017 | 87 | 17 | N/A | 19 | N/A |
| 12/31/2016 | 83 | 16 | N/A | 20 | N/A |
| 9/30/2016 | 79 | 15 | N/A | N/A | N/A |
| 6/30/2016 | 75 | 15 | N/A | 23 | N/A |
| 3/31/2016 | 72 | 14 | N/A | 22 | N/A |
| 12/31/2015 | 69 | 14 | N/A | 21 | N/A |
| 9/30/2015 | 67 | 14 | N/A | 19 | N/A |
| 6/30/2015 | 66 | 14 | N/A | 18 | N/A |
| 3/31/2015 | 65 | 13 | N/A | 17 | N/A |
| 12/31/2014 | 63 | 13 | N/A | 17 | N/A |
| 9/30/2014 | 62 | 13 | N/A | 16 | N/A |
| 6/30/2014 | 62 | 12 | N/A | 15 | N/A |
| 3/31/2014 | 61 | 12 | N/A | 14 | N/A |
| 12/31/2013 | 59 | 11 | N/A | 14 | N/A |
| 9/30/2013 | 57 | 11 | N/A | 13 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AMSDas prognostizierte Gewinnwachstum (14.8% pro Jahr) liegt über der Sparquote (1.8%).
Ertrag vs. Markt: AMSDie Erträge des Unternehmens (23.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (14.2% pro Jahr).
Hohe Wachstumserträge: AMSEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: AMSDie Einnahmen des Unternehmens (18.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.6% pro Jahr).
Hohe Wachstumseinnahmen: AMSDie Einnahmen des Unternehmens (18.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: AMSDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.4%).